Saturday, July 06, 2019 4:35:55 PM
Emmaus Life Sciences has a FDA approved drug for Sickle Cell disease, Endari. This will be followed by MYND spinning off their telepsychiatry/AI PEER 4.0 device into a newly formed NASDAQ listed company, TeleMYnd...
In doing some research it seems the market opportunity for Sickle Cell is quite large and expected to more than double in the next four years.
Sickle Cell market size $2.1B growing to $4.5B by 2025. Also Emmaus is listed as the #1 key player!
here is the study...
https://www.marketwatch.com/press-release/sickle-cell-anemia-therapeutics-market-size-to-surge-at-110-cagr-and-hit-usd-4500-million-by-2025-2019-04-09
Recent MYND News
- Mynd Announces Fiscal Year 2023 Results • PR Newswire (US) • 03/27/2024 10:30:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:05:12 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:01:59 AM
- Mynd.ai to Ring NYSE First Trade Bell on February 5th • PR Newswire (US) • 02/02/2024 01:00:00 PM
- Promethean introduces new game-changing whiteboard app at FETC 2024 • PR Newswire (US) • 01/24/2024 01:24:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM